ESR1 gene amplification in breast cancer: a common phenomenon?
暂无分享,去创建一个
Anne Vincent-Salomon | Olivier Delattre | Virginie Raynal | Nadège Gruel | A. Vincent-Salomon | O. Delattre | C. Lucchesi | N. Gruel | V. Raynal | Carlo Lucchesi
[1] Olivier Delattre,et al. Two types of chromosome 1p losses with opposite significance in gliomas , 2005, Annals of neurology.
[2] Emmanuel Barillot,et al. Analysis of array CGH data: from signal ratio to gain and loss of DNA regions , 2004, Bioinform..
[3] A. Vincent-Salomon,et al. Calibration of immunohistochemistry for assessment of HER2 in breast cancer: results of the French Multicentre GEFPICS * Study , 2003, Histopathology.
[4] Emmanuel Barillot,et al. BAC array CGH distinguishes mutually exclusive alterations that define clinicogenetic subtypes of gliomas , 2007, International journal of cancer.
[5] A. Vincent-Salomon,et al. High sensitivity and specificity of immunohistochemistry for the detection of hormone receptors in breast carcinoma: comparison with biochemical determination in a prospective study of 793 cases , 2000, Histopathology.
[6] O. Mariani,et al. ASK1 (MAP3K5) as a potential therapeutic target in malignant fibrous histiocytomas with 12q14–q15 and 6q23 amplifications , 2004, Genes, chromosomes & cancer.
[7] G. Sauter,et al. Estrogen receptor alpha (ESR1) gene amplification is frequent in breast cancer , 2007, Nature Genetics.
[8] A. Vincent-Salomon,et al. Identification of typical medullary breast carcinoma as a genomic sub-group of basal-like carcinomas, a heterogeneous new molecular entity , 2007, Breast Cancer Research.
[9] Emmanuel Barillot,et al. Spatial normalization of array-CGH data , 2006, BMC Bioinformatics.
[10] Céline Rouveirol,et al. VAMP: Visualization and analysis of array-CGH, transcriptome and other molecular profiles , 2006, Bioinform..